Evelo Biosciences' market value is the price at which a share of Evelo Biosciences trades on a public exchange. It measures the collective expectations of Evelo Biosciences investors about its performance. Evelo Biosciences is selling at 2.0E-4 as of the 23rd of January 2026; that is 60 percent decrease since the beginning of the trading day. The stock's open price was 5.0E-4. With this module, you can estimate the performance of a buy and hold strategy of Evelo Biosciences and determine expected loss or profit from investing in Evelo Biosciences over a given investment horizon. Check out Evelo Biosciences Correlation, Evelo Biosciences Volatility and Evelo Biosciences Alpha and Beta module to complement your research on Evelo Biosciences.
Please note, there is a significant difference between Evelo Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Evelo Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evelo Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Evelo Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Evelo Biosciences' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Evelo Biosciences.
0.00
10/25/2025
No Change 0.00
0.0
In 3 months and 1 day
01/23/2026
0.00
If you would invest 0.00 in Evelo Biosciences on October 25, 2025 and sell it all today you would earn a total of 0.00 from holding Evelo Biosciences or generate 0.0% return on investment in Evelo Biosciences over 90 days. Evelo Biosciences is related to or competes with HST Global. Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammator... More
Evelo Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Evelo Biosciences' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Evelo Biosciences upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Evelo Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Evelo Biosciences' standard deviation. In reality, there are many statistical measures that can use Evelo Biosciences historical prices to predict the future Evelo Biosciences' volatility.
Evelo Biosciences is out of control given 3 months investment horizon. Evelo Biosciences secures Sharpe Ratio (or Efficiency) of 0.0724, which denotes the company had a 0.0724 % return per unit of risk over the last 3 months. We were able to break down and interpolate nineteen different technical indicators, which can help you to evaluate if expected returns of 3.85% are justified by taking the suggested risk. Use Evelo Biosciences Mean Deviation of 16.89, standard deviation of 54.2, and Variance of 2938.14 to evaluate company specific risk that cannot be diversified away. Evelo Biosciences holds a performance score of 5 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 8.39, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Evelo Biosciences will likely underperform. Use Evelo Biosciences mean deviation, jensen alpha, as well as the relationship between the Jensen Alpha and rate of daily change , to analyze future returns on Evelo Biosciences.
Auto-correlation
-0.26
Weak reverse predictability
Evelo Biosciences has weak reverse predictability. Overlapping area represents the amount of predictability between Evelo Biosciences time series from 25th of October 2025 to 9th of December 2025 and 9th of December 2025 to 23rd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Evelo Biosciences price movement. The serial correlation of -0.26 indicates that nearly 26.0% of current Evelo Biosciences price fluctuation can be explain by its past prices.
Correlation Coefficient
-0.26
Spearman Rank Test
-0.34
Residual Average
0.0
Price Variance
0.0
Pair Trading with Evelo Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evelo Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evelo Biosciences will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Evelo Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evelo Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evelo Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evelo Biosciences to buy it.
The correlation of Evelo Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evelo Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evelo Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Evelo Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Other Information on Investing in Evelo Pink Sheet
Evelo Biosciences financial ratios help investors to determine whether Evelo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Evelo with respect to the benefits of owning Evelo Biosciences security.